OBJECTIVE: We report the use of 'gamma knife' (GK) radiosurgery in 25 patients with pituitary adenomas not cured despite conventional therapy, including external beam radiotherapy. PATIENTS AND METHODS: All patients had previously received conventional radiotherapy for a mean of 11.8 years prior to receiving GK; 23 out of 25 had also undergone pituitary surgery on at least one occasion. Seventeen had hyperfunctioning adenomas that still required medical therapy without an adequate biochemical control--ten somatotroph adenomas, six corticotroph adenomas and one prolactinoma, while eight patients had non-functioning pituitary adenomas (NFPAs). RESULTS: Following GK, mean GH fell by 49% at 1 year in patients with somatotroph tumours. Serum IGF...
Introduction Stereotactic radiosurgery (SRS) is a valuable treatment option for persistent and/or re...
OBJECTIVE: To analyze pituitary adenoma volume changes after gamma knife radiosurgery (GKRS) in pati...
Radiation has been used both as primary and adjuvant treatment for pituitary tumours for several dec...
OBJECTIVE: We report the use of 'gamma knife' (GK) radiosurgery in 25 patients with pituitary adenom...
Objectives : Stereotactic radiosurgery using gamma-knife in adjunct to transsphenoidal pituitary sur...
International audiencePituitary adenomas are benign tumors that can be either secreting (acromegaly,...
To describe and evaluate outcomes of Gamma Knife radiosurgery (GK) for the treatment of pituitary tu...
Stereotactic radiosurgery has been an important treatment modality in the treatment of pituitary ade...
Purpose: To study early treatment outcomes and complications of Gamma Knife Radiosurgery(GKRS) in pa...
The application of transsphenoidal microsurgery in the management of pituitary microadenoma, long re...
ObjectiveRecurrent or residual adenomas are frequently treated with Gamma Knife radiosurgery (GKRS)....
We report the use of stereotactic radiosurgery delivered through an adapted linear accelerator [ster...
In the management of pituitary microadenomas, although transsphenoidal microsurgery presents a very ...
Objective. Single-session radiosurgery with Gamma Knife (GK) may be a potential adjuvant treatment i...
Stereotactic radiosurgery (SRS) is a valuable treatment option for persistent and/or recurrent acrom...
Introduction Stereotactic radiosurgery (SRS) is a valuable treatment option for persistent and/or re...
OBJECTIVE: To analyze pituitary adenoma volume changes after gamma knife radiosurgery (GKRS) in pati...
Radiation has been used both as primary and adjuvant treatment for pituitary tumours for several dec...
OBJECTIVE: We report the use of 'gamma knife' (GK) radiosurgery in 25 patients with pituitary adenom...
Objectives : Stereotactic radiosurgery using gamma-knife in adjunct to transsphenoidal pituitary sur...
International audiencePituitary adenomas are benign tumors that can be either secreting (acromegaly,...
To describe and evaluate outcomes of Gamma Knife radiosurgery (GK) for the treatment of pituitary tu...
Stereotactic radiosurgery has been an important treatment modality in the treatment of pituitary ade...
Purpose: To study early treatment outcomes and complications of Gamma Knife Radiosurgery(GKRS) in pa...
The application of transsphenoidal microsurgery in the management of pituitary microadenoma, long re...
ObjectiveRecurrent or residual adenomas are frequently treated with Gamma Knife radiosurgery (GKRS)....
We report the use of stereotactic radiosurgery delivered through an adapted linear accelerator [ster...
In the management of pituitary microadenomas, although transsphenoidal microsurgery presents a very ...
Objective. Single-session radiosurgery with Gamma Knife (GK) may be a potential adjuvant treatment i...
Stereotactic radiosurgery (SRS) is a valuable treatment option for persistent and/or recurrent acrom...
Introduction Stereotactic radiosurgery (SRS) is a valuable treatment option for persistent and/or re...
OBJECTIVE: To analyze pituitary adenoma volume changes after gamma knife radiosurgery (GKRS) in pati...
Radiation has been used both as primary and adjuvant treatment for pituitary tumours for several dec...